Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Journal of Cancer|July 9, 2016
MET Inhibition in Clear Cell Renal Cell CarcinomaZuoquan Xie, Young H Lee, Marta Boeke, et al.
Journal of Translational Medicine|July 16, 2010
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032Jill C Rubinstein, Mario Sznol, Anna C Pavlick, et al.
Journal of Neuro-Oncology|March 10, 2017
Comparing available criteria for measuring brain metastasis response to immunotherapyJack M Qian, Amit Mahajan, James B Yu, et al.
Cancer Cell International|January 16, 2014
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinomaSaadia A Aziz, Joshua A Sznol, Laurence Albiges, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2011
Plasma markers for identifying patients with metastatic melanomaHarriet M Kluger, Kathleen Hoyt, Antonella Bacchiocchi, et al.
Journal of Translational Medicine|August 13, 2011
Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancerAymen A Elfiky, Saadia A Aziz, Patricia J Conrad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Phosphatidylinositol-3-kinase as a therapeutic target in melanomaSaadia A Aziz, Michael Davies, Elah Pick, et al.
Human Pathology|December 17, 2009
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarraysJanice M Mehnert, Mary M McCarthy, Lucia Jilaveanu, et al.
JCO Precision Oncology|July 12, 2021
Tumor DNA Mutations From Intraparenchymal Brain Metastases Are Detectable in CSFStephanie Kim Cheok, Azeet Narayan, Anna Arnal-Estape, et al.
Pageof 18